MedTrace Logo

Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses

NCT00762476 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 411

Last updated 2012-04-16

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the efficacy of 3804-250A in the prevention of the common cold. The study will also evaluate whether 3804-250A prevents rhinovirus infection, a virus that causes many common colds.

Conditions

  • Common Cold

Interventions

DRUG

3804-250A

* topical product * apply 2 pumps * apply at least every 4 hours or after hand washing

DRUG

3804-291

* topical * apply 2 pumps * apply at least every 4 hours or after hand washing

Sponsors & Collaborators

  • Hill Top Research

    collaborator INDUSTRY

  • TKL Research, Inc.

    collaborator INDUSTRY

  • The Dial Corporation

    lead INDUSTRY

Principal Investigators

  • Ronald B Turner, MD · University of Virginia School of Medicine

  • Michael E Casser, MD · TKL Research, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00762476 on ClinicalTrials.gov